Journal
MATURITAS
Volume 82, Issue 3, Pages 308-313Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.maturitas.2015.07.020
Keywords
Genitourinary syndrome of menopause; Vulvovaginal atrophy; Menopausal hormone therapy; Nonhormonal vaginal therapy; Sexuality
Categories
Funding
- Shionogi, Spain
Ask authors/readers for more resources
The term genitourinary syndrome of menopause (GSM) emerged following a consensus conference held in May 2013. GSM is a more descriptive term than vulvovaginal atrophy (VVA) and does not imply pathology. However there are concerns that GSM is all encompassing and includes not only symptoms resulting from estrogen deficiency, but also those arising from the effects of ageing and other processes on the bladder and pelvic floor. Focusing on symptoms related to estrogen deficiency, the update provides a practical guide for health and allied health professionals on the impact of GSM on women and their partners, assessment, management and areas for future research. As GSM is a chronic condition, long term therapy is required. Hormonal, nonhormonal, laser and alternative and complementary therapies are described. (C) 2015 Published by Elsevier Ireland Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available